Sign in / Join Now
ETFs & Funds
's perifosine had absolutely no effect or was detrimental to colon
patients, the DSMB would have stopped the trial in August.
;-) That's what I'm thinking!
Add a reply...
Latest StockTalks »
people get AEZS breaking news and analysis by email alert.
Get email alerts on AEZS »
AEterna Zentaris, Inc.
Get latest price
From other sites
Aeterna Zentaris Reports Third Quarter 2016 Financial And Operating Results
at TheStreet (Nov 8, 2016)
Aeterna Zentaris Announces Closing Of US$7,560,000 Registered Direct Offering Of Common Shares And Warrants
at TheStreet (Nov 1, 2016)
Aeterna Zentaris To Announce Third Quarter 2016 Financial And Operating Results On November 8, 2016
at TheStreet (Oct 28, 2016)
Aeterna Zentaris Announces US$7,560,000 Registered Direct Offering Of Common Shares And Warrants
at TheStreet (Oct 27, 2016)
Aeterna Zentaris (AEZS) Jumps: Stock Adds 5.2% in Session
at Zacks.com (Oct 21, 2016)